Experts say children in pain from rheumatic diseases or other causes may have more discomfort because they can’t downregulate the pain as effectively as adults
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
Legal Updates: As Opioids for Pain Treatment Come Under Greater Scrutiny, Controlled Substance Agreements Matter More
These contracts can communicate a physician’s expectations for a pain treatment plan and guidelines for safe use by their patients
Two Inflammatory Conditions—Polymyalgia Rheumatica and Giant Cell Arteritis—Share Clinical Connection
Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) have common clinical and epidemiologic links, but they need not occur synchronously
Rheumatology Chooses Wisely
ACR identifies five practices, therapies, or procedures physicians and patients should question
The ACR Releases Top 5 Things as Part of Choosing Wisely Campaign
On February 21, the ACR–along with 16 other national medical societies–released its list of Five Things Patients and Physicians Should Question in Rheumatology.
Panel Addresses Drug Safety Issues in Rheumatology Products
Black box warnings, TNF inhibitors, and tofacitinib discussed
Tackle Tricky Lung Complications in Connective Tissue Disease
Guidance for diagnosing and treating interstitial lung disease complications
First Annual Rheumatoid Awareness Day to Be Held February 2
New day of action and outreach aims to spread awareness of rheumatoid arthritis
How to Evaluate Shoulder Pain
The common causes of shoulder pain and diagnostic tests that rheumatologists need to know
- « Previous Page
- 1
- …
- 670
- 671
- 672
- 673
- 674
- …
- 824
- Next Page »